Live Analyst Rating Changes 37988 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Adam Vogel
C-H

Adam Vogel

Craig-Hallum
Wall Street Analyst
★★★★☆
#932
on 13Foresight · ranked by our own returns
33%
Success Rate
+2.2%
Average Return
6 of 18 calls profitable · +56.6% vs benchmark
S&P 500 (SPY)
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 33% of Adam Vogel's ratings turned a profit when each position was held for 1 year — averaging +2.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

37 Buy 1 Hold 0 Sell
Adam's Stock Coverage 8 ratings · 2026-10-06
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
ATHE
Alterity Therapeutics
 Oct 05, 2026 BUY Strong Buy
+213.2% avg upside
8 analysts
$15.00
365.75% Upside
 · ·
IMNM
Immunome
 Aug 12, 2026 BUY Strong Buy
+58.6% avg upside
18 analysts
$36.00
70.08% Upside
 -25.3% ·
LBRX
LB Pharmaceuticals, Inc.
 Aug 12, 2026 BUY Strong Buy
+56.8% avg upside
9 analysts
$45.00
30.05% Upside
 -18.5% ·
PEPG
PepGen Inc.
 Aug 06, 2026 BUY Strong Buy
+352.1% avg upside
9 analysts
$11.00
366.07% Upside
 -5.4% ·
ACRS
Aclaris Therapeutics
 Aug 06, 2026 BUY Strong Buy
+135.3% avg upside
16 analysts
$10.00
134.26% Upside
 -27.9% ·
DSGN
Design Therapeutics
 Aug 04, 2026 BUY Strong Buy
+46.3% avg upside
9 analysts
$22.00
77.08% Upside
 -7.3% ·
MPLT
MapLight Therapeutics, Inc.
 Jul 28, 2026 BUY Strong Buy
+217.5% avg upside
13 analysts
$25.00
169.57% Upside
 -20.2% ·
HIT
Health In Tech, Inc. Class A
 Apr 10, 2026 BUY Strong Buy
+226.2% avg upside
3 analysts
 — -41.6% ·
🔒 3 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Adam Vogel — Frequently Asked Questions
How accurate are Adam Vogel's stock ratings?
Based on the calls 13Foresight could measure, about 33% of Adam's ratings were profitable over a one-year hold, with an average return of +2.2% per rating, or +56.6% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Adam ranked on 13Foresight?
Adam Vogel is currently ranked #932 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Adam cover?
Adam most recently has ratings on ATHE, IMNM, LBRX, PEPG, ACRS, DSGN, MPLT, HIT. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.